OGT has unveiled next-generation sequencing (NGS) automation capabilities across its SureSeq NGS portfolio, compatible with the Hamiton NGS STAR Line. The latest advancement in OGT’s ongoing SureSeq investment, these automated workflows help laboratories optimise resources and deliver turnaround time targets.
Rising sample volumes are putting clinical research labs under pressure. Maintaining consistent throughput while managing labour-intensive library preparation is a growing bottleneck, one that OGT has addressed head on. Developed in close collaboration with laboratory partners and workflow specialists, automation-enabled SureSeq workflows remove manual intervention at the most time-consuming stages of NGS library preparation, supporting high-throughput processing across multiple sample types.
The result: a faster, more consistent process for NGS results without additional resource burden.
Combined with OGT’s wide range of haematological malignancy-focused SureSeq NGS panels, including the recently launched SureSeq Myeloid MRD Plus NGS Panel, SureSeq solutions give clinical research labs the throughput and confidence to extract clear, comprehensive genomics insights at scale.